Over the past decade, the incidence of IMN has shown an increasing trend and it has now become a leading cause of ESRD.
← all excerpts
Exploring the mechanism of Kemofang in treating idiopathic membranous nephropathy based on LC-MS/MS combined with network pharmacology, molecular docking, and molecular dynamics simulation.
1
—
—